FROM LAB TO PATIENT: HOW MEDICINES ARE APPROVED

FROM LAB TO PATIENT: HOW MEDICINES ARE APPROVED

Take a look at this short overview of how new medicines are developed within the lab in order to treat a patients illness, to reaching the shelves and effectively the patients. The video discusses the clinical trial process and how labs require European Medicines Agency approval to release that product.

If you are interested in exploring how MIAS Pharma can assist your organisation, contact us at +353 01 846 3605 or info@miaspharma.com.


Source EMA: https://www.youtube.com/watch?v=568SI1W-ekE